Attached files
file | filename |
---|---|
8-K - FORM 8-K - GeoVax Labs, Inc. | c04009e8vk.htm |
Exhibit 99.1
GEOVAX LABS, INC. FINANCING UPDATE
ATLANTA, GA, July 28, 2010 GeoVax Labs, Inc. (OTC BB: GOVX), an Atlanta-based, biopharmaceutical
firm (the Company) developing human vaccines and therapeutics for diseases caused by HIV-1 (Human
Immunodeficiency Virus), previously announced that it has deferred the offering it filed with the
Securities and Exchange Commission to sell shares and warrants. The Company cited a decline in its
share price that coincided with turbulent general stock market conditions as a reason for its
decision.
Management is reassessing fundraising options and anticipates commencing a smaller offering of
securities sometime after Labor Day. Details for such an offering have not been finalized, but it
will likely not include selling stockholders. Current thinking is to conduct a $5 million to $10
million offering to retail and institutional investors. However, before offering or selling any
securities, the Company will amend its registration statement on file with the Securities and
Exchange Commission to reflect changes in the terms of the proposed offering, and to update other
information.
GeoVax President and CEO Robert T. McNally, Ph.D. noted, The offering we deferred was intended to
give us the financial resources to be much more aggressive in our approach to our clinical pathways
but turned out not to be achievable as our stock price declined and general market conditions
deteriorated. The underlying fundamentals at GeoVax and the strength of our science, however, have
not changed. Neither has our enthusiasm for the Companys prospects or our excitement about
developments with our vaccines. We remain bullish about our science and the potential for our
vaccines and therapeutics.
Given the current conditions in the broad market and a stock price we believe undervalues GeoVax,
the decision was made to defer the offering and rethink our strategy, Dr. McNally continued. The
reverse stock split we implemented earlier this year brings us closer to meeting requirements for
eventual listing on a major stock exchange, which remains a goal for the Company. A successful
smaller offering later this year will give the Company funds it needs to make solid progress into
2012 while being less dilutive to our shareholders.
Final decisions on conducting a smaller offering will not be made until later.
A registration statement relating to these securities has been filed with the Securities and
Exchange Commission but has not yet become effective. These securities may not be sold nor may
offers to buy be accepted prior to the time the registration statement becomes effective.
Forward-Looking Statements
Certain statements contained in this release, including those relating to postponement of the offering, as well as statements containing words like plans, expects, and other similar expressions in this press release or the Companys other public communications, are forward-looking statements that involve a number of risks and uncertainties. All such forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those in the forward-looking statements. These risks and uncertainties include, but are not limited to: that we may not obtain the additional funding needed to continue operations after the end of 2010, the possible adverse impact on the market price of the Companys shares of common stock due to the dilutive effect of the securities which may be sold in the offering, and the possible adverse effect of continuing unfavorable market conditions, as well as other risks and uncertainties, such as those detailed from time to time in the Companys Securities and Exchange Commission filings, including Risk Factors in the Companys most recent Form 10-K. The Company does not undertake to update its forward-looking statements.
Certain statements contained in this release, including those relating to postponement of the offering, as well as statements containing words like plans, expects, and other similar expressions in this press release or the Companys other public communications, are forward-looking statements that involve a number of risks and uncertainties. All such forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those in the forward-looking statements. These risks and uncertainties include, but are not limited to: that we may not obtain the additional funding needed to continue operations after the end of 2010, the possible adverse impact on the market price of the Companys shares of common stock due to the dilutive effect of the securities which may be sold in the offering, and the possible adverse effect of continuing unfavorable market conditions, as well as other risks and uncertainties, such as those detailed from time to time in the Companys Securities and Exchange Commission filings, including Risk Factors in the Companys most recent Form 10-K. The Company does not undertake to update its forward-looking statements.
###